Detalhe da pesquisa
1.
Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer.
Tumour Biol
; 46(s1): S341-S353, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545291
2.
Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients.
Diagnostics (Basel)
; 11(2)2021 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33672622
3.
Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Anticancer Res
; 34(5): 2357-62, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24778043